Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-01

Clinical Trial Update: A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A [Phase 3]

View source ↗

Summary

A Phase 3 trial of Adynovate in previously treated Chinese teenagers and adults with severe Hemophilia A has completed, and the trial results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADYNOVATE (efmoroctocog alfa)

Snippet

Sponsor: Takeda | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2025-05-01